Issn Print: 0923-7534
Publication Date: 2018/01/01
Safety and efficacy of alternating treatment with EP2006, a filgrastim biosimilar, and reference filgrastim: a phase III, randomised, double-blind clinical study in the prevention of severe neutropenia in patients with breast cancer receiving myelosuppressive chemotherapy
K Blackwell; P Gascon; A Krendyukov; S Gattu; Y Li; N Harbeck
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.